« Back to Record
Henzi, B. C., Putananickal, N., Schmidt, S., Nagy, S., Rubino–Nacht, D., Schaedelin, S., Amthor, H., Childs, A. –., Deconinck, N., Horrocks, I., Houwen–van Opstal, S., Laugel, V., Lobato, M. L., Osorio, A. N., Schara–Schmidt, U., Spinty, S., von Moers, A., Lawrence, F., Hafner, P., Dorchies, O. O., & Fischer, D. (2025). Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double–blind, placebo–controlled, phase 3 trial (TAMDMD Group B). Neuromuscular disorders, 47, 105275. doi:10.1016/j.nmd.2025.105275
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/390929



